Ho WS - Search Results

1

Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.

Ho WS, Hiley CR. Ho WS, et al. J Pharm Pharmacol. 2004 Jul;56(7):869-75. doi: 10.1211/0022357023682. J Pharm Pharmacol. 2004. PMID: 15233865

2

Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.

Ho WS, Hiley CR. Ho WS, et al. Br J Pharmacol. 2003 Apr;138(7):1320-32. doi: 10.1038/sj.bjp.0705160. Br J Pharmacol. 2003. PMID: 12711633 Free PMC article.

3

Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx.

Ho WS, Hiley CR. Ho WS, et al. Br J Pharmacol. 2003 Jun;139(3):585-97. doi: 10.1038/sj.bjp.0705280. Br J Pharmacol. 2003. PMID: 12788818 Free PMC article.

4

Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.

White R, Ho WS, Bottrill FE, Ford WR, Hiley CR. White R, et al. Among authors: ho ws. Br J Pharmacol. 2001 Oct;134(4):921-9. doi: 10.1038/sj.bjp.0704333. Br J Pharmacol. 2001. PMID: 11606334 Free PMC article.

5

Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries.

Vuylsteke A, Davidson HJ, Ho WS, Ritchie AJ, Callingham BA, White R, Hiley CR. Vuylsteke A, et al. Among authors: ho ws. J Cardiovasc Pharmacol. 2001 Apr;37(4):394-405. doi: 10.1097/00005344-200104000-00006. J Cardiovasc Pharmacol. 2001. PMID: 11300652

6

U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance.

Rademacher DJ, Patel S, Ho WS, Savoie AM, Rusch NJ, Gauthier KM, Hillard CJ. Rademacher DJ, et al. Among authors: ho ws. Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2694-701. doi: 10.1152/ajpheart.00978.2004. Epub 2005 Feb 4. Am J Physiol Heart Circ Physiol. 2005. PMID: 15695564 Free article.

7

N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.

Parmar N, Ho WS. Parmar N, et al. Among authors: ho ws. Br J Pharmacol. 2010 Jun;160(3):594-603. doi: 10.1111/j.1476-5381.2009.00622.x. Epub 2010 Feb 5. Br J Pharmacol. 2010. PMID: 20136843 Free PMC article.

8

Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.

Hill MN, Ho WS, Meier SE, Gorzalka BB, Hillard CJ. Hill MN, et al. Among authors: ho ws. Eur J Pharmacol. 2005 Dec 28;528(1-3):99-102. doi: 10.1016/j.ejphar.2005.10.058. Epub 2005 Dec 1. Eur J Pharmacol. 2005. PMID: 16324692

9

Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Rademacher DJ, et al. Among authors: ho ws. Neuropharmacology. 2008 Jan;54(1):108-16. doi: 10.1016/j.neuropharm.2007.06.012. Epub 2007 Jun 29. Neuropharmacology. 2008. PMID: 17675104

10

Vascular actions of calcimimetics: role of Ca²(+) -sensing receptors versus Ca²(+) influx through L-type Ca²(+) channels.

Thakore P, Ho WS. Thakore P, et al. Among authors: ho ws. Br J Pharmacol. 2011 Feb;162(3):749-62. doi: 10.1111/j.1476-5381.2010.01079.x. Br J Pharmacol. 2011. PMID: 20958288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters